Sept 11, 2026 at the Allison Inquiry Dr. Peter McCullough explains the treatment approach he says he uses…

Sept 11, 2026 at the Allison Inquiry Dr. Peter McCullough explains the treatment approach he says he uses for patients suffering from what he describes as CV-19 VX injury syndromes. He begins with research on nattokinase, saying: “Fortunately, the Japanese… found that a natural exogenous enzyme does reliably dissolve the spike protein… That enzyme is nattokinase.” McCullough says nattokinase is derived from fermented soy or chickpeas and argues that it can help break down spike protein. He then discusses bromelain, an enzyme derived from pineapple, and curcumin, explaining why he combines all three in what he calls the “McCullough Protocol Base Spike Protein Detoxification.” He says: “The spike protein is job one. The people are loaded with it, and we have to get rid of it.” And later: “Every VX injured patient should be doing this. I haven’t found a single VX injured patient get better without it. Not a one. Not a one.” McCullough also describes one of his patients with myocarditis and a blood clot, saying it took roughly 20 months for the patient’s antibody levels to fall substantially while undergoing treatment, and that the patient’s symptoms eventually resolved. He argues that patients need treatments aimed at what he believes is the underlying cause rather than simply masking symptoms, and says the process can take years. McCullough then directly challenges Canadian health authorities to investigate these approaches: “Public Health Agency Canada needs to get a move on.” And then: “My phone is on. I’ll take a call anytime, night or day.” This was part of Dr. Peter McCullough’s testimony at the Allison Inquiry in Ottawa, where he called for more research, greater recognition of VX injuries, and more treatment options for patients who say they have been left without answers.